Petra B Ross-Macdonald

Title: Petra B Ross-Macdonald: Innovator in Cancer Treatment

Introduction

Petra B Ross-Macdonald is a prominent inventor based in Pennington, NJ (US). She has made significant contributions to the field of cancer treatment, particularly in renal cell carcinoma. With a total of 2 patents, her work is recognized for its innovative approaches to combating this challenging disease.

Latest Patents

Her latest patents focus on the treatment of renal cell carcinoma. The first patent discloses methods for treating a subject afflicted with a tumor derived from renal cell carcinoma. The methods involve administering a first dose of an anti-PD-1 antibody or an anti-PD-L1 antibody, followed by a second dose. This approach is particularly effective for subjects exhibiting differential expression in biomarker genes such as CTLA-4, TIGIT, and PD-L2 after the first dose.

Career Highlights

Petra is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work has been instrumental in enhancing treatment options for patients suffering from renal cell carcinoma.

Collaborations

She collaborates with Jason Samuel Simon, contributing to the innovative research environment at her company. Their combined expertise fosters advancements in cancer treatment methodologies.

Conclusion

Petra B Ross-Macdonald's contributions to cancer treatment through her patents and collaborations highlight her as a key figure in the field. Her innovative approaches are paving the way for more effective therapies for renal cell carcinoma.